Arocell

Arocell, based in South Korea, is focused on developing premium skincare solutions that rejuvenate and enhance skin vitality, leveraging advanced ingredients for effective anti-aging benefits. Arocell operates under FICC Co. , Ltd, specializing in skincare products designed to target aging and environmental damage. Founded in 2019 in Seoul, South Korea, the company has undertaken two significant deals, with the most recent being a Series B funding round on September 18, 2025, raising KRW 4 billion, led by Hanwha Investment & Securities, with participation from Capstone Partners and Timeworks Investment.

There are no indications of structural changes or pivots in the company’s operations since its founding. Arocell, a brand under FICC Co. , Ltd, specializes in skincare products designed to rejuvenate and revitalize skin. Their core offerings include a range of products such as the Super Power Cream and Hydrogel Collagen Mask, both infused with growth factors aimed at enhancing skin elasticity and hydration.

These products function by delivering essential nutrients and collagen directly to the skin, targeting aging and environmental damage. AROCELL primarily serves consumers looking for effective anti-aging solutions and is marketed in various geographical regions, including North America, Europe, and select markets in Asia. The brand positions itself as a premium skincare line, appealing to a diverse client base comprising individuals seeking advanced skincare solutions. The revenue structure of Arocell is primarily generated through direct-to-consumer sales of its skincare products.

Customers typically purchase items like the Super Power Cream and Hydrogel Collagen Mask directly from the company’s website or through exclusive retail partnerships. Transactions may involve one-time purchases or the establishment of subscription services for recurring deliveries of their products. Arocell's pricing strategy reflects its premium positioning in the skincare market, with specific pricing plans established for each product line, ensuring both accessibility for consumers and profitability for the company. This transactional model allows AROCELL to maintain a steady revenue stream while building brand loyalty amongst its clientele.

In September 2025, Arocell raised KRW 4 billion in Series B funding led by Hanwha Investment & Securities, with participation from Capstone Partners and Timeworks Investment. The company plans to utilize this funding to enhance brand awareness and product exposure through media marketing and to establish new logistics hubs. Arocell is also focused on developing new skincare products and expanding into additional markets, though specific details about new products or targeted regions have not been disclosed.